BHC — Bausch Health Companies Share News
0.000.00%
Last trade - 00:00- $2.37bn
- $22.29bn
- $10.27bn
Bausch Health Companies Inc expected to post earnings of 88 cents a share - Earnings Preview
Bausch Health tumbles on unconfirmed report of bankruptcy
Bausch Health denies report of considering bankruptcy filing (updated)
Bausch Health denies report of bankruptcy filing
Brief: Bausch Health Companies On July 15 Appointed Jean-Jacques Charhon As Company's Executive Vice President And CFO, Effective As Of Aug 19
Bausch wins US appeal to block Alvogen generic of diarrhea drug
Brief: Bausch Can Block Alvogen From Copying Xifaxan Diarrhea Drug Until 2029-Us Appeals Court
Brief: Bausch Health Companies Inc - CEO Thomas J. Appio 2023 Total Compensation $15.9 Million Versus. $13.2 Million In 2022 - SEC Filing
Canada Stocks: Toronto healthcare stocks rise in flat market, Canada Goose slides
Bausch Health Companies Inc reports results for the quarter ended in December - Earnings Summary
Bausch Health Companies Inc expected to post earnings of $1.00 a share - Earnings Preview
RCS - Bausch Health Comp. - Bausch Health Clarifies Certifications in China
Brief: Icahn Enterprises Says It Holds 15.42% Stake In Southwest Gas Holdings As Of Sept 30 - SEC Filing
Some October distressed bond volumes beat March 2020 levels -JPMorgan
Bausch Health Companies Inc expected to post earnings of 90 cents a share - Earnings Preview
Brief: Bausch Health Companies - FDA Approves Cabtreo(Tm) Topical Gel For Treatment Of Acne Vulgaris In Patients Twelve Years Of Age And Older
Canada Stocks: TSX ends lower as Fed sticks to inflation fight
Bausch Health jumps as Jefferies turns bullish
U.S. RESEARCH ROUNDUP-Bausch Health Companies, Chewy, First Citizens Bancshares